BIIBBenzingaThese Analysts Increase Their Forecasts On Biogen After Upbeat Q3 Results
Biogen Inc (NASDAQ:BIIB) on Wednesday posted better-than-expected earnings for the third quarter.
benzinga.comRead the article
You’re reading free news for BIIB. Sign up free for 3 full 5D deep-dives a month, or start a 14-day Pro trial to unlock the full 5D analysis on more than 3,000 US-listed stocks - no credit card required.
Start free trial- Price
- $249.01
- Day
- -1.82%
- Mkt Cap
- $36.81B
- 52W Range
- $148.51 – $258.78
- Volume
- 1.17M
- Beta
- 0.17